Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2010-01, Vol.31 (9), p.1018-1027
Main Authors: ROTMAN, Y., BORG, B. B., SOZA, A., FELD, J. J., MODI, A. A., LOOMBA, R., LUTCHMAN, G., RIVERA, E., DOO, E., GHANY, M. G., HELLER, T., NEUMANN, A. U., LIANG, T. J., HOOFNAGLE, J. H.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0269-2813
1365-2036
DOI:10.1111/j.1365-2036.2010.04263.x